Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis
Am J Kidney Dis
.
2022 Jul;80(1):151-153.
doi: 10.1053/j.ajkd.2022.03.002.
Epub 2022 Apr 1.
Authors
Caroline M Hsu
1
,
Eduardo K Lacson
2
,
Harold J Manley
3
,
Gideon N Aweh
3
,
Dana Miskulin
4
,
Doug Johnson
3
,
Daniel E Weiner
4
Affiliations
1
Tufts Medical Center, Boston, Massachusetts. Electronic address:
[email protected]
.
2
Tufts Medical Center, Boston, Massachusetts; Dialysis Clinic, Inc., Nashville, Tennessee.
3
Dialysis Clinic, Inc., Nashville, Tennessee.
4
Tufts Medical Center, Boston, Massachusetts.
PMID:
35378208
PMCID:
PMC8972976
DOI:
10.1053/j.ajkd.2022.03.002
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Antibodies, Viral
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Renal Dialysis*
SARS-CoV-2
Substances
Antibodies, Viral
COVID-19 Vaccines